Trudy D. Luce

Learn More
Functional studies have demonstrated that adrenoceptor agonist-evoked relaxation is mediated primarily by beta3-adrenergic receptors (ARs) in human bladder. Thus, the use of selective beta3-AR agonists in the pharmacological treatment of overactive bladder is being explored. The present studies investigated the effects of a novel selective beta3-AR agonist,(More)
Functional studies have demonstrated that adrenoceptor agonist-evoked relaxation is mediated primarily by 3-adrenergic receptors (ARs) in human bladder. Thus, the use of selective 3-AR agonists in the pharmacological treatment of overactive bladder is being explored. The present studies investigated the effects of a novel selective 3-AR agonist, (R)-3(More)
  • 1